BRUCY: Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions

Sponsor
The Christie NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05662839
Collaborator
(none)
50
1
12

Study Details

Study Description

Brief Summary

In an attempt to reduce patient flow into the hospital we are going to assess the use of penile cytological brushings and dermoscopy in diagnosing cancer or non-cancer conditions of the penis.

Condition or Disease Intervention/Treatment Phase
  • Device: Cytological Brushing
N/A

Detailed Description

Currently the standard of care pathway for all patients suspected of having penile cancer involves the need for a penile biopsy under local (LA) or general anaesthetic (GA). We hope to assess the feasibility of cytololgical brushings and the patient experience of the use of such a technique. Additionally, we will make initial comparison on the concordance between cytological brushing and dermoscope photo vs actual biopsy only.

Importantly for this study, all patients will be offered standard of care: a biopsy under LA or GA. The additional procedures of the cytological brushing and dermoscope photo will be done in an out-patient clinic setting (with no anaesthetic).

If it can be shown that the inclusion of the cytological brushing and dermoscope photo have comparative results over current standard of care histological biopsy, this will provide sufficient evidence to expand this study to acquire more data.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients will be assigned to one of two groups. Each group will receive standard of care and the additional procedures being investigated.Patients will be assigned to one of two groups. Each group will receive standard of care and the additional procedures being investigated.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Research Arm

Each group will undergo the same study procedures; Dermoscope Cytological brushing Complete questionnaire on experience of the cytological brushing SoC treatment

Device: Cytological Brushing
All participants will undergo cytological brushing to collect cell samples for analysis

Outcome Measures

Primary Outcome Measures

  1. Does cytology results compare equally with standard histological biopsy for detecting cancer [Through study completion, expected to be 12 months]

    Concordance of cytology vs Histopathology i.e. is the cytology assessment equal to histopathology results when detecting cancer

  2. Does the use of dermoscopy photography enable us to identify abnormal cellular changes that compare equally to the results obtained with standard histological biopsy. [Through study completion, expected to be 12 months]

    Concordance of dermoscopy vs Histopathology in detecting cancer i.e. does the use of dermoscopy photographs enable us to identify cancer and compare equally to results obtained by histopathology

Secondary Outcome Measures

  1. Patient satisfaction with cytological brushing diagnostic method being tested [Through study completion, expected to be 12 months]

    All patients on study will be asked their views on the cytology brushing technique being used to gauge their satisfaction and experience of the new diagnostic method being tested

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. All patients requiring either diagnostic biopsy or WLE (wide local excision) of a lesion of the penis

  2. Age > 18 years

  3. Written informed consent provided by the patient

  4. Subject has been scheduled for surgical intervention, with a biopsy procedure being a part of the surgical plan

Exclusion Criteria:
  1. Subject is unfit for surgery upon surgeon's assessment.

  2. Unable to provide consent

  3. Those with terminal disease

  4. Those with palpable lymph nodes

  5. Other coincident cancers

  6. Previous radiotherapy treatment to the penis, bladder, prostate, anus

  7. Subject is deprived of liberty or under guardianship

  8. Subject is not able to follow and understand the procedures of the study due to mental state or other reasons

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Christie NHS Foundation Trust

Investigators

  • Principal Investigator: Vijay Sangar, The Christie NHS FT

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Christie NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT05662839
Other Study ID Numbers:
  • CFTSp203
First Posted:
Dec 23, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The Christie NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022